Welcome to the official website of BioCoreUSA Corp!
  • Cores:
    100
    CASES:
    25
    Core Diameter(mm):
    1
    Thickness(µm):
    5
    Row number:
    10
    Column number:
    10
    Tissue Array Type:
    FFPE
    Species:
    Human
FUR1001
$225.00
Add To Collect

Description: Endometrial cancer tissue array for antibody screening, including pathology grade, TNM and clinical stage, 25 cases/100 cores

Details: Endometrial cancer tissue microarray for antibody screening, containing 25 cases of endometrioid adenocarcinoma, grade II*III, quadruple cores per case, divided into four identical 25 cores arrays

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • Malignant(I)
  • Malignant(Ia)
  • Malignant(Ib)
  • Malignant(Ic)
  • Malignant(IIb)
  • Malignant(II)
  • Malignant(IIIc)
  • Malignant(IVa)
  • _ma
TISSUE ARRAYS
FUR1001
1
2
3
4
5
6
7
8
9
10
A
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
B
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
C
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
D
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
E
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
F
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
G
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
H
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
I
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
J
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
_ma
FUR1001
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type
A1
1 45 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant
A2
2 43 F Uterus Endometrioid adenocarcinoma 2 T4N0M0 IVa Malignant
A3
3 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
A4
4 64 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 Ia Malignant
A5
5 42 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
A6
6 45 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant
A7
7 43 F Uterus Endometrioid adenocarcinoma 2 T4N0M0 IVa Malignant
A8
8 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
A9
9 64 F Uterus Endometrioid adenocarcinoma (chronic inflammation of smooth muscle) * T1aN0M0 Ia Malignant
A10
10 42 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
B1
11 53 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 Ib Malignant
B2
12 62 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
B3
13 40 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
B4
14 47 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 Ib Malignant
B5
15 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
B6
16 53 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 Ib Malignant
B7
17 62 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
B8
18 40 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
B9
19 47 F Uterus Endometrioid adenocarcinoma (chronic inflammation of smooth muscle) * T1bN0M0 Ib Malignant
B10
20 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
C1
21 56 F Uterus Endometrioid adenocarcinoma 2 T3N1M0 IIIc Malignant
C2
22 48 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
C3
23 61 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 Ic Malignant
C4
24 45 F Uterus Endometrioid adenocarcinoma 2 T3N1M0 IIIc Malignant
C5
25 51 F Uterus Endometrioid adenocarcinoma (chronic inflammation of smooth muscle) * T2bN0M0 IIb Malignant
C6
26 56 F Uterus Endometrioid adenocarcinoma 2 T3N1M0 IIIc Malignant
C7
27 48 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
C8
28 61 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 Ic Malignant
C9
29 45 F Uterus Endometrioid adenocarcinoma 2 T3N1M0 IIIc Malignant
C10
30 51 F Uterus Endometrioid adenocarcinoma (sparse) * T2bN0M0 IIb Malignant
D1
31 43 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
D2
32 23 F Uterus Endometrioid adenocarcinoma 2 T3N2M0 IIIc Malignant
D3
33 46 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 Ic Malignant
D4
34 54 F Uterus Endometrioid adenocarcinoma 3 T1N0M0 I Malignant
D5
35 48 F Uterus Endometrioid adenocarcinoma with squamous metaplasia 3 T2N0M0 II Malignant
D6
36 43 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
D7
37 23 F Uterus Endometrioid adenocarcinoma 2 T3N2M0 IIIc Malignant
D8
38 46 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 Ic Malignant
D9
39 54 F Uterus Endometrioid adenocarcinoma 3 T1N0M0 I Malignant
D10
40 48 F Uterus Endometrioid adenocarcinoma with squamous metaplasia 3 T2N0M0 II Malignant
E1
41 62 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 Ib Malignant
E2
42 56 F Uterus Endometrioid adenocarcinoma 2 T1N1M0 IIIc Malignant
E3
43 51 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 Ic Malignant
E4
44 55 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
E5
45 45 F Uterus Endometrioid adenocarcinoma 3 T1N0M0 I Malignant
E6
46 62 F Uterus Endometrioid adenocarcinoma (sparse) * T1bN0M0 Ib Malignant
E7
47 56 F Uterus Endometrioid adenocarcinoma 2 T1N1M0 IIIc Malignant
E8
48 51 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 Ic Malignant
E9
49 55 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
E10
50 45 F Uterus Endometrioid adenocarcinoma 3 T1N0M0 I Malignant
F1
51 45 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant
F2
52 43 F Uterus Endometrioid adenocarcinoma 2 T4N0M0 IVa Malignant
F3
53 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
F4
54 64 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 Ia Malignant
F5
55 42 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
F6
56 45 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant
F7
57 43 F Uterus Endometrioid adenocarcinoma 2 T4N0M0 IVa Malignant
F8
58 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
F9
59 64 F Uterus Endometrioid adenocarcinoma (chronic inflammation of smooth muscle) * T1aN0M0 Ia Malignant
F10
60 42 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
G1
61 53 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 Ib Malignant
G2
62 62 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
G3
63 40 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
G4
64 47 F Uterus Endometrioid adenocarcinoma (chronic inflammation of smooth muscle) * T1bN0M0 Ib Malignant
G5
65 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
G6
66 53 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 Ib Malignant
G7
67 62 F Uterus Endometrioid adenocarcinoma (sparse) 2 T1N0M0 I Malignant
G8
68 40 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
G9
69 47 F Uterus Endometrioid adenocarcinoma (chronic inflammation of smooth muscle) * T1bN0M0 Ib Malignant
G10
70 56 F Uterus Endometrioid adenocarcinoma (sparse) 2 T1N0M0 I Malignant
H1
71 56 F Uterus Endometrioid adenocarcinoma 2 T3N1M0 IIIc Malignant
H2
72 48 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
H3
73 61 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 Ic Malignant
H4
74 45 F Uterus Endometrioid adenocarcinoma 2 T3N1M0 IIIc Malignant
H5
75 51 F Uterus Endometrioid adenocarcinoma (chronic inflammation of smooth muscle) * T2bN0M0 IIb Malignant
H6
76 56 F Uterus Endometrioid adenocarcinoma (sparse) 2 T3N1M0 IIIc Malignant
H7
77 48 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
H8
78 61 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 Ic Malignant
H9
79 45 F Uterus Endometrioid adenocarcinoma 2 T3N1M0 IIIc Malignant
H10
80 51 F Uterus Endometrioid adenocarcinoma 2 T2bN0M0 IIb Malignant
I1
81 43 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
I2
82 23 F Uterus Endometrioid adenocarcinoma 2 T3N2M0 IIIc Malignant
I3
83 46 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 Ic Malignant
I4
84 54 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
I5
85 48 F Uterus Endometrioid adenocarcinoma with squamous metaplasia 3 T2N0M0 II Malignant
I6
86 43 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
I7
87 23 F Uterus Endometrioid adenocarcinoma 2 T3N2M0 IIIc Malignant
I8
88 46 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 Ic Malignant
I9
89 54 F Uterus Endometrioid adenocarcinoma 3 T1N0M0 I Malignant
I10
90 48 F Uterus Endometrioid adenocarcinoma with squamous metaplasia 3 T2N0M0 II Malignant
J1
91 62 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 Ib Malignant
J2
92 56 F Uterus Endometrioid adenocarcinoma 2 T1N1M0 IIIc Malignant
J3
93 51 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 Ic Malignant
J4
94 55 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
J5
95 45 F Uterus Endometrioid adenocarcinoma 3 T1N0M0 I Malignant
J6
96 62 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 Ib Malignant
J7
97 56 F Uterus Endometrioid adenocarcinoma 2 T1N1M0 IIIc Malignant
J8
98 51 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 Ic Malignant
J9
99 55 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
J10
100 45 F Uterus Endometrioid adenocarcinoma 3 T1N0M0 I Malignant
_malignant_melanoma_
Find overlapping cases with this tissue array:
  • FUR1001
    File Format: .xlsx
    Release Date: 2025-01-17 16:01:03
    Download
0.781554s